NobleBlocks

Research index

Use of rituximab to decrease panel-reactive antibodies.

Balfour, Fiore, Graff and 1 other

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation1 May 2005

NobleIDark:/48914/w1/20260515/7B8161AADOI10.1016/j.healun.2004.01.006

Paywalled

The full text is at the publisher

You can read the abstract here, or open it at the publisher.

Read at the publisher

Abstract

Patients with pre-formed antibodies may be at increased risk of rejection after organ transplantation. In this report, we describe the use of rituximab to decrease the percentage of pre-formed antibodies in a pediatric heart transplant recipient.

Discussion

Citations

More

Suggest a correction or report